Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women.

Brache V, Sitruk-Ware R, Williams A, Blithe D, Croxatto H, Kumar N, Kumar S, Tsong YY, Sivin I, Nath A, Sussman H, Cochon L, Miranda MJ, Reyes V, Faundes A, Mishell D Jr.

Contraception. 2012 May;85(5):480-8. doi: 10.1016/j.contraception.2011.10.003. Epub 2011 Dec 15.

2.

A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception.

Huang Y, Jensen JT, Brache V, Cochon L, Williams A, Miranda MJ, Croxatto H, Kumar N, Sussman H, Hoskin E, Plagianos M, Roberts K, Merkatz R, Blithe D, Sitruk-Ware R.

Contraception. 2014 Dec;90(6):565-74. doi: 10.1016/j.contraception.2014.08.006. Epub 2014 Aug 12.

3.

Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial.

Chabbert-Buffet N, Pintiaux-Kairis A, Bouchard P; VA2914 Study Group..

J Clin Endocrinol Metab. 2007 Sep;92(9):3582-9. Epub 2007 Jun 19.

PMID:
17579200
4.

A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol.

Weisberg E, Fraser IS, Mishell DR Jr, Lacarra M, Darney P, Jackanicz TM.

Contraception. 1999 May;59(5):305-10.

PMID:
10494484
5.

A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate.

Jesam C, Cochon L, Salvatierra AM, Williams A, Kapp N, Levy-Gompel D, Brache V.

Contraception. 2016 Apr;93(4):310-6. doi: 10.1016/j.contraception.2015.12.015. Epub 2016 Jan 4.

PMID:
26764121
6.

Investigational hormone receptor agonists as ongoing female contraception: a focus on selective progesterone receptor modulators in early clinical development.

Nelson AL.

Expert Opin Investig Drugs. 2015;24(10):1321-30. doi: 10.1517/13543784.2015.1076791. Epub 2015 Aug 8. Review.

PMID:
26289789
7.

Immediate pre-ovulatory administration of 30 mg ulipristal acetate significantly delays follicular rupture.

Brache V, Cochon L, Jesam C, Maldonado R, Salvatierra AM, Levy DP, Gainer E, Croxatto HB.

Hum Reprod. 2010 Sep;25(9):2256-63. doi: 10.1093/humrep/deq157. Epub 2010 Jul 15.

PMID:
20634186
8.

Vaginal ring delivery of selective progesterone receptor modulators for contraception.

Jensen JT.

Contraception. 2013 Mar;87(3):314-8. doi: 10.1016/j.contraception.2012.08.038. Epub 2012 Oct 4. Review.

9.

Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.

Westhoff CL, Torgal AH, Mayeda ER, Petrie K, Thomas T, Dragoman M, Cremers S.

Am J Obstet Gynecol. 2012 Jul;207(1):39.e1-6. doi: 10.1016/j.ajog.2012.04.022. Epub 2012 Apr 28. Erratum in: Am J Obstet Gynecol. 2013 Apr;208(4):326.

10.

Effects of ulipristal acetate on human embryo attachment and endometrial cell gene expression in an in vitro co-culture system.

Berger C, Boggavarapu NR, Menezes J, Lalitkumar PG, Gemzell-Danielsson K.

Hum Reprod. 2015 Apr;30(4):800-11. doi: 10.1093/humrep/dev030. Epub 2015 Mar 3.

PMID:
25740886
11.

Preclinical experience with two selective progesterone receptor modulators on breast and endometrium.

Kloosterboer HJ, Deckers GH, Schoonen WG, Hanssen RG, Rose UM, Verbost PM, Hsiu JG, Williams RF, Hodgen GD.

Steroids. 2000 Oct-Nov;65(10-11):733-40.

PMID:
11108884
12.

The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study.

Cameron ST, Berger C, Michie L, Klipping C, Gemzell-Danielsson K.

Hum Reprod. 2015 Jul;30(7):1566-72. doi: 10.1093/humrep/dev115. Epub 2015 May 20.

PMID:
25994664
13.

Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.

Mäkäräinen L, van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H.

Fertil Steril. 1998 Apr;69(4):714-21.

PMID:
9548163
14.

Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques.

Brenner RM, Slayden OD, Nath A, Tsong YY, Sitruk-Ware R.

Contraception. 2010 Apr;81(4):336-42. doi: 10.1016/j.contraception.2009.11.004. Epub 2009 Dec 16.

15.

A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women.

Dinh A, Sriprasert I, Williams AR, Archer DF.

Contraception. 2015 May;91(5):360-7. doi: 10.1016/j.contraception.2015.01.008. Epub 2015 Jan 14. Review.

PMID:
25596512
16.
17.

Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg).

Sierra-Ramírez JA, Lara-Ricalde R, Lujan M, Velázquez-Ramírez N, Godínez-Victoria M, Hernádez-Munguía IA, Padilla A, Garza-Flores J.

Contraception. 2011 Dec;84(6):565-70. doi: 10.1016/j.contraception.2011.03.014. Epub 2011 May 11.

PMID:
22078184
18.
19.

Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.

Katkam RR, Gopalkrishnan K, Chwalisz K, Schillinger E, Puri CP.

Am J Obstet Gynecol. 1995 Sep;173(3 Pt 1):779-87.

PMID:
7573244
20.

Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring.

Weisberg E, Fraser IS, Lacarra M, Mishell DR Jr, Alvarez F, Brache V, Nash HA.

Contraception. 1999 May;59(5):311-8.

PMID:
10494485

Supplemental Content

Support Center